Donald G. Payan

2015

In 2015, Donald G. Payan earned a total compensation of $1.4M as Executive Vice President, of Discovery and Research at Rigel Pharmaceuticals, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$237,817
Option Awards$544,840
Salary$559,571
Other$9,906
Total$1,352,134

Payan received $559.6K in salary, accounting for 41% of the total pay in 2015.

Payan also received $237.8K in non-equity incentive plan, $544.8K in option awards and $9.9K in other compensation.

Rankings

In 2015, Donald G. Payan's compensation ranked 6,485th out of 13,638 executives tracked by ExecPay. In other words, Payan earned more than 52.4% of executives.

ClassificationRankingPercentile
All
6,485
out of 13,638
52nd
Division
Manufacturing
2,433
out of 5,190
53rd
Major group
Chemicals And Allied Products
882
out of 1,854
52nd
Industry group
Drugs
707
out of 1,528
54th
Industry
Pharmaceutical Preparations
552
out of 1,182
53rd
Source: SEC filing on March 28, 2016.

Payan's colleagues

We found four more compensation records of executives who worked with Donald G. Payan at Rigel Pharmaceuticals in 2015.

2015

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2015

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2015

Dolly Vance

Rigel Pharmaceuticals

General Counsel

2015

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

You may also like